Royalty Pharma Plc Net Asset Momentum
Royalty Pharma Plc net asset momentum. Royalty Pharma Plc (RPRX) recorded a net asset momentum of -6.1% as of December 2025, with net assets of $9.71 Billion USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore Royalty Pharma Plc (RPRX) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Royalty Pharma Plc (2000–2025)
Net asset momentum of Royalty Pharma Plc from 2000 to 2025. This chart tracks Royalty Pharma Plc's year-over-year net asset growth across 26 annual reporting periods from 2000 to 2025. The most recent momentum reading is -6.1%, with net assets of $9.71 Billion USD as of December 2025. See Royalty Pharma Plc (RPRX) net assets for net asset value and shareholders' equity analysis.
Royalty Pharma Plc Net Asset Momentum by Year (2000–2025)
Royalty Pharma Plc net asset momentum by year from 2000 to 2025. The table below shows the complete annual net asset history for Royalty Pharma Plc from 2000 to 2025, covering 26 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see Royalty Pharma Plc (RPRX) market capitalisation.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $9.71 Billion | $19.62 Billion | $9.91 Billion | ▼ -6.1% |
| 2024 | $10.34 Billion | $18.22 Billion | $7.88 Billion | ▲ +2.6% |
| 2023 | $10.08 Billion | $16.38 Billion | $6.30 Billion | ▲ +5.9% |
| 2022 | $9.53 Billion | $16.81 Billion | $7.29 Billion | ▼ -7.1% |
| 2021 | $10.25 Billion | $17.52 Billion | $7.27 Billion | ▼ -31.6% |
| 2020 | $14.97 Billion | $21.10 Billion | $6.12 Billion | ▲ +143.8% |
| 2019 | $6.14 Billion | $12.45 Billion | $6.31 Billion | ▲ +34.9% |
| 2018 | $4.55 Billion | $11.37 Billion | $6.82 Billion | ▲ +1.9% |
| 2017 | $4.47 Billion | $11.37 Billion | $6.90 Billion | ▲ +0.2% |
| 2016 | $4.46 Billion | $10.48 Billion | $6.02 Billion | ▼ -5.0% |
| 2015 | $4.70 Billion | $10.82 Billion | $6.12 Billion | ▲ +10571.1% |
| 2014 | $44.02 Million | $46.94 Million | $2.92 Million | ▼ -41.6% |
| 2013 | $75.42 Million | $78.98 Million | $3.55 Million | ▲ +227.5% |
| 2012 | $23.03 Million | $26.83 Million | $3.80 Million | ▲ +393.7% |
| 2011 | $4.67 Million | $6.06 Million | $1.40 Million | ▲ +47.3% |
| 2010 | $3.17 Million | $4.46 Million | $1.30 Million | ▲ +463.5% |
| 2009 | $562.00K | $2.96 Million | $2.40 Million | ▼ -96.4% |
| 2008 | $15.61 Million | $22.60 Million | $6.99 Million | ▼ -35.1% |
| 2007 | $24.06 Million | $27.60 Million | $3.54 Million | ▲ +534.8% |
| 2006 | $3.79 Million | $7.85 Million | $4.06 Million | ▼ -77.6% |
| 2005 | $16.95 Million | $17.68 Million | $727.00K | ▲ +183.0% |
| 2004 | $5.99 Million | $6.61 Million | $614.00K | ▼ -74.5% |
| 2003 | $23.49 Million | $24.03 Million | $541.00K | ▼ -12.5% |
| 2002 | $26.85 Million | $27.37 Million | $519.00K | ▼ -12.2% |
| 2001 | $30.57 Million | $36.91 Million | $6.34 Million | ▼ -1.6% |
| 2000 | $31.06 Million | $40.37 Million | $9.31 Million | — |